首页> 外文期刊>Journal of Solid Tumors >High tumour-associated macrophages infiltration is correlated with poor survival outcome in classical Hodgkin’s lymphoma
【24h】

High tumour-associated macrophages infiltration is correlated with poor survival outcome in classical Hodgkin’s lymphoma

机译:肿瘤相关的巨噬细胞浸润与经典霍奇金淋巴瘤生存不良相关

获取原文
       

摘要

Background: Classical Hodgkin’s lymphoma (cHL) represents the majority of HLs with a relatively good prognosis. In 20% ofpatients, primary treatment fails. Prediction of treatment failure is critical. A gene signature of tumour associated macrophages(TAM) correlated with response to treatment as CD68 positive TAM was found to be associated with shortened survival. We aimto investigate the relation CD68+TAM infiltration to patients’ outcome.Patients and Methods: Pathological materials of 115 patients with cHL were used. Clinical characteristics of patients werecollected from the records. CD68 immunostaining was performed to determine the number of infiltrating TAM and subsequentlyfollowed by stratification of results. Results of CD68 immunostaining were statistically analysed to correlate the extent of CD68+TAM infiltration with clinicopathological characteristics, treatment outcome, and patients’ survival.Results: High CD68+TAM infiltration was observed in more patients of cHL (96/115 of patients = 83.5%). High CD68+TAMinfiltration was associated with extranodal presentation (p = .001), and higher stage (p = .022). No associations with otherclinicopathological parameters were found. High CD68+TAM infiltration was not found to be an independent predictor oftreatment outcome. High CD68+TAM infiltration correlated with disease free survival (DFS) (log-rank = 4.505, p = .034) but notwith disease specific survival (DSS) (log-rank = 1.371, p = .242).Conclusions: The results of our study support the adverse prognostic effect of high TAM in cHL. Technical standardisation ofCD68 immunostaining is required to establish TAM infiltration as a prognostic predictor. Also in vivo and in vitro cHL modelshave to be established for proper understanding of the role of CD68 in modulating the TAM in cHL.
机译:背景:经典霍奇金淋巴瘤(cHL)代表大多数HL,预后相对较好。在20%的患者中,初级治疗失败。预测治疗失败至关重要。发现肿瘤相关巨噬细胞(TAM)的基因特征与治疗反应相关,因为CD68阳性TAM与缩短的生存期有关。我们的目的是研究CD68 + TAM浸润与患者预后的关系。患者与方法:使用115例cHL患者的病理材料。从记录中收集患者的临床特征。进行CD68免疫染色以确定浸润的TAM的数目,随后进行结果分层。对CD68免疫染色的结果进行统计分析,以将CD68 + TAM浸润的程度与临床病理特征,治疗结果和患者生存率相关联。结果:在更多的cHL患者中观察到高CD68 + TAM浸润(96/115例患者= 83.5 %)。高CD68 + TAMin滤过与结外表现(p = .001)和更高阶段有关(p = .022)。没有发现与其他临床病理参数的关联。未发现高CD68 + TAM浸润是治疗结果的独立预测因子。高CD68 + TAM浸润与无病生存期(DFS)相关(对数秩= 4.505,p = .034),但与疾病特异性生存率(DSS)不相关(对数秩= 1.371,p = .242)。结论:结果我们的研究支持高TAM对cHL的不良预后作用。要使TAM浸润作为预后指标,就需要对CD68免疫染色进行技术标准化。还必须建立体内和体外cHL模型,以正确理解CD68在调节cHL中TAM中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号